Szabo IL - Search Results

1

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy.

Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Pai R, et al. Among authors: szabo il. Nat Med. 2002 Mar;8(3):289-93. doi: 10.1038/nm0302-289. Nat Med. 2002. PMID: 11875501

2

Indomethacin delays gastric restitution: association with the inhibition of focal adhesion kinase and tensin phosphorylation and reduced actin stress fibers.

Szabó IL, Pai R, Jones MK, Ehring GR, Kawanaka H, Tarnawski AS. Szabó IL, et al. Exp Biol Med (Maywood). 2002 Jun;227(6):412-24. doi: 10.1177/153537020222700607. Exp Biol Med (Maywood). 2002. PMID: 12037131

3

NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.

Husain SS, Szabo IL, Tamawski AS. Husain SS, et al. Among authors: szabo il. Am J Gastroenterol. 2002 Mar;97(3):542-53. doi: 10.1111/j.1572-0241.2002.05528.x. Am J Gastroenterol. 2002. PMID: 11922545 Review.

4

Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation.

Baatar D, Jones MK, Pai R, Kawanaka H, Szabo IL, Moon WS, Kitano S, Tarnawski AS. Baatar D, et al. Among authors: szabo il. Am J Pathol. 2002 Mar;160(3):963-72. doi: 10.1016/S0002-9440(10)64918-8. Am J Pathol. 2002. PMID: 11891194 Free PMC article.

5

Esophageal ulceration activates keratinocyte growth factor and its receptor in rats: implications for ulcer healing.

Baatar D, Kawanaka H, Szabo IL, Pai R, Jones MK, Kitano S, Tarnawski AS. Baatar D, et al. Among authors: szabo il. Gastroenterology. 2002 Feb;122(2):458-68. doi: 10.1053/gast.2002.31004. Gastroenterology. 2002. PMID: 11832460

6

von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis.

Jones MK, Szabó IL, Kawanaka H, Husain SS, Tarnawski AS. Jones MK, et al. Among authors: szabo il. FASEB J. 2002 Feb;16(2):264-6. doi: 10.1096/fj.01-0589fje. Epub 2001 Dec 28. FASEB J. 2002. PMID: 11772947

7

Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI 3-kinase-Akt signaling pathway.

Kawanaka H, Jones MK, Szabo IL, Baatar D, Pai R, Tsugawa K, Sugimachi K, Sarfeh IJ, Tarnawski AS. Kawanaka H, et al. Among authors: szabo il. Hepatology. 2002 Feb;35(2):393-402. doi: 10.1053/jhep.2002.30958. Hepatology. 2002. PMID: 11826414

8

Nonsteroidal anti-inflammatory drugs inhibit re-epithelialization of wounded gastric monolayers by interfering with actin, Src, FAK, and tensin signaling.

Pai R, Szabo IL, Giap AQ, Kawanaka H, Tarnawski AS. Pai R, et al. Among authors: szabo il. Life Sci. 2001 Nov 9;69(25-26):3055-71. doi: 10.1016/s0024-3205(01)01412-6. Life Sci. 2001. PMID: 11758831

9

MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.

Husain SS, Szabo IL, Pai R, Soreghan B, Jones MK, Tarnawski AS. Husain SS, et al. Among authors: szabo il. Life Sci. 2001 Nov 9;69(25-26):3045-54. doi: 10.1016/s0024-3205(01)01411-4. Life Sci. 2001. PMID: 11758830

10

Activation of hypoxia inducible factor-1alpha in gastric mucosa in response to ethanol injury: a trigger for angiogenesis?

Szabo IL, Kawanaka H, Jones MK, Pai R, Soreghan BA, Baatar D, Husain SS, Tarnawski AS. Szabo IL, et al. Life Sci. 2001 Nov 9;69(25-26):3035-44. doi: 10.1016/s0024-3205(01)01410-2. Life Sci. 2001. PMID: 11758829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results